Altamira Therapeutics Ltd - Warrants (29/03/2028) Intangible Assets

The latest intangible assets for CYTOW is $4.6M as of December 2024. That compares with $3.9M in the prior-year period — up 18.8% year over year. Investors often review this figure alongside Altamira Therapeutics Ltd - Warrants (29/03/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CYTOW's intangible assets moved from $3.9M to $4.6M — a 18.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Altamira Therapeutics Ltd - Warrants (29/03/2028)'s operating scale or balance-sheet position.

A intangible assets figure of $4.6M for CYTOW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CYTOW's intangible assets ($4.6M), review year-over-year change from $3.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Altamira Therapeutics Ltd - Warrants (29/03/2028)'s intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.